YOUCOUNT LAUNCHES INITIATIVE FOR KIDNEY DISEASE URINE TESTS

YOUCOUNT LAUNCHES INITIATIVE FOR KIDNEY DISEASE URINE TESTS

January 9, 2022 Vancouver, BC - YouCount Inc. (www.youcount.io) ("YouCount" or the "Company") is pleased to announce that it is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) and the Canadian Space Agency (CSA) to support a research and development project that will develop an Albumin-to-creatinine Ratio (ACR) Test for Patients in Remote Communities or Isolated Areas for the identification and management of patients with Kidney Disease.

NRC IRAP, in collaboration with the Health Beyond team (HB) of the CSA, have launched a program to support technologies aimed at addressing needs for the Canadian healthcare and wellness sector and that could have a potential for future adaptation for space utilization.

Nick Dechev, CEO and Co-Founder commented: “YouCount’s testing platform uses machine-vision and proprietary sensor technology to accurately detect and analyze biomarkers in urine in remote locations independent of trained medical staff.”

Teo Dechev, COO and Co-Founder commented: “This project will integrate the ACR urine test for management in kidney disease into our digital platform, HealthCheck, for early detection monitoring of biomarkers important in kidney health.”

Follow our weekly updates on: LinkedIn and Twitter: @YouCount

YouCount Inc. www.youcount.io

YouCount provides bio-markers analysis, through at home, clinically accurate, easy-to-use, inexpensive, urine tests. YouCount’s proprietary testing platform uses machine-vision and sensor technology to accurately detect and analyze bio-markers in urine. Our technology platform first screens and then tracks long-term bio-markers patterns, enabling users to make informed health-related decisions in real-time, thereby improving outcomes.

Caution Concerning Forward-Looking Statements

This News Release contains forward-looking statements. Forward-looking statements can be identified by the use of forward-looking words such as "will", "expect", "intend", "plan", "estimate", "anticipate", "believe" or "continue" or similar words or the negative thereof. The material assumptions that were applied in making the forward-looking statements in this News Release include expectations as to the outcomes of the Company’s projects, the Company's future strategy and business plan and execution of the Company's existing plans. We caution readers of this News Release not to place undue reliance on forward looking statements contained in this News Release, as there can be no assurance that they will occur and they are subject to a number of uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors include general economic and market conditions, research results, changes in law, regulatory processes, the status of YouCount's assets and financial condition, actions of competitors and the ability to implement business strategies and pursue business opportunities. The forward-looking statements contained in this News Release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this News Release are made as of the date of this News Release and the Board undertakes no obligation to publicly update such forward-looking statements, except as required by law. Shareholders are cautioned that all forward-looking statements involve risks and uncertainties.